Researchers have found the first evidence that autoimmunity plays a role in Parkinson’s disease, showing that T cells recognize α-synuclein peptides.
An international research team have shown that gene editing reverses Huntington’s symptoms without off-target effects in a mouse model.
Anthranilic acid is associated with greater risk of dementia, along with other kynurenine pathway metabolites.
The hypothesis that antidepressant response has a relevant genetic component was initially suggested by the observation that this phenotype clusters in families.
This review explores the limitations of the present technology and current challenges of SCS before reviewing some of the most important recent advances.